BioSpace News Archive

SoftWave Tissue Regeneration Technologies announced its DermaGold an advanced wound care technology, has received an Innovative Technology contract from Vizient, Inc.

Ocean Biomedical, Inc. announced that it has entered into a private placement pursuant to a securities purchase agreement with Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B for the issuance and sale of a total anticipated $25 million facility of Senior Secured Convertible Promissory Notes.

Oncotelic Inc. is thrilled to announce their participation in the BIO International Convention.

OncoSec Medical Incorporated (NASDAQ: ONCS) (the Company or OncoSec) today announced a Type C meeting held with the US Food and Drug Administration (FDA) on May 15, 2023.

Korio, Inc., a technology-first Randomization & Trial Supply Management company, is pleased to announce its collaboration with The Leukemia & Lymphoma Society on its innovative Beat AML® Master Clinical Trial.

Arsenal Biosciences, Inc. today announced that it will present preclinical data on its integrated circuit T cell therapies, AB-1015 and AB-2100, in an oral abstract session and three posters at the American Society of Gene and Cell Therapy (ASGCT) annual meeting in Los Angeles, Calif., May 16-20, 2023.

Ray Therapeutics today announced an upsized and oversubscribed $100M Series A financing round led by Novo Holdings A/S, and joined by Deerfield Management, Norwest Venture Partners, Platanus, MRL Ventures Fund, the therapeutics-focused corporate venture fund of Merck & Co., Inc., and existing investor 4BIO Capital.

Ensoma announced the closing of an extension of its Series B financing by $50 million, bringing the total size of the funding round to $135 million.

ElevateBio, LLC today announced four poster presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting taking place May 16-20, 2023, in Los Angeles, CA.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of Lisa Rojkjaer, M.D., as Chief Medical Officer.